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Introduction: Biological meshes are a potential alternative to the synthetic meshes to
avoid complications and are used in a contaminated field for incarcerated inguinal hernias.
The clinical experiences gained with biological meshes for repair of inguinal hernias are
presented in this review.
Materials and methods: In a literature search of the Medline database using the key
word “Biological mesh,” 2,277 citations were found. There remained 14 studies in which
biological meshes had been used to repair inguinal hernias.
Results: In prospective randomized trials, the use of polypropylene vs. biological meshes
was compared in open inguinal hernia repair. There was no difference in the recurrence
rate, but differences were observed in the postsurgical pain incidence in favor of the
biological mesh. In the remaining retrospective studies, the recurrence rates were also
acceptable. The biological mesh was used successfully in a potentially contaminated
setting.
Conclusion: Inguinal hernias can be repaired with biological meshes with reasonable
recurrence rate, also as an alternative in a potentially contaminated field.
Keywords: biological mesh, inguinal hernia, contaminated field, recurrence, pain
Introduction
The Guidelines of the European Hernia Society state, based on evidence level 1 A, that operation
techniques using mesh result in fewer recurrences than techniques, which do not use mesh (1).
Although mesh repair appears to reduce the likelihood of chronic groin pain rather than increase it
(1), mesh can cause considerable pain and stiffness around the groin and affect physical functioning
(2). This has led to various types of mesh being engineered, with a growing interest in lighter weight
polypropylene (PP) meshes (2), absorbable meshes (3), and biological meshes. For open inguinal
hernia repair the use of light-weight PP meshes was not associated with an increased risk of hernia
recurrence. Light-weight PP meshes reduce the incidence of chronic groin pain as well as the risk of
developing other groin symptoms (4). To avoid complications, the use of absorbable meshes – such
as thosemade of lactic acid polymer or lactic and glycolic acid copolymers – has been proposed. This
exposes the patient to inevitable hernia recurrence because the inflammatory response, through a
hydrolytic reaction, completely digests the implanted prosthetic material (3, 5).
Another potential alternative to the synthetic meshes is biological meshes which, unlike
absorbable meshes, are not completely degraded; instead, these induce a remodeling process, i.e.,
the biological mesh is incorporated into the host through the reproduction of new site-specific
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tissue. The clinical experiences gained with biological meshes for
repair of inguinal hernias are presented below.
Materials and Methods
A literature search of the Medline database was performed using
the PubMed search engine. The following key words were used:
Biological mesh; inguinal hernia OR Groin hernia AND Bio-
logical mesh OR Biomesh OR Biological. 2,277 citations were
found. After checking the title and abstracts, there remained seven
prospective randomized trials (RCTs) (5–11). In one of these seven
RCTs (Table 1), the results were reported for a smaller sample size
(6) from the entire study (5) at an earlier follow-up time point. For
two RCTs, only an abstract is available (8, 9). Recently, two meta-
analyses were also published reporting on three and four RCTs,
respectively (12, 13). Furthermore, there are five retrospective case
series available (14–18), in which biological meshes had been used
to repair inguinal hernias and the corresponding follow-up results
reported (Table 2). These are also described below.
Results
In a prospective randomized double-blind trial (5, 6), Lichten-
stein’s inguinal hernia repair was compared using a PP or a small
intestine submucosa (SIS)mesh. Seventymale patients underwent
Lichtenstein’s hernioplasty, with 35 patients in the SIS group and
35 patients in the PP group. At 3 years after surgery, there were
two deaths (5.7%) in the PP group and one death (2.9%) in the
SIS group (NS). Only one recurrence (2.9%) was seen in the PP
group (NS). Although a significant decrease in the postsurgical
pain incidence was never observed among patients in the SIS
group, a significantly lower degree of pain was detected at rest
and on coughing at 1, 3, and 6months and on movement at 1, 3,
and 6months and 1, 2, and 3 years. A significant decrease in the
postsurgical incidence and degree of discomfort when coughing
and moving were observed among patients in the SIS group at 3
and 6months and at 1, 2, and 3 years after surgery. The authors
concluded that SIS hernioplasty seems to be a safe and effective
procedure.
TABLE 1 | Characteristics and outcomes of RCTs on inguinal hernia repair with the use of biologic vs. polypropylene mesh.
Reference Study design Patients
characteristic
Mesh
material
Intervention
details
Follow-up Outcome Conflict of
interest
LoE
(8) Prospective
blinded
randomized trial
n= 140
primary
inguinal
hernias
Collagen mesh
vs. polypropylene
Open
procedures
12months One recurrence in each
group
NR 1b
Abstract only
(6) Prospective
double-blinded
randomized trial
n= 20
primary
inguinal
hernias
SIS vs.
polypropylene
Lichtenstein in
general or spinal
anesthesia
6months No recurrence, no wound
infection, no
post-hemioplasty acute
and chronic
pain/discomfort,
parenteral/oral analgesic
consumption were lower in
surgisis group
NR 1b
(7) Prospective
randomized trial
n= 45 male
patients with
inguinal
hernia
SIS vs.
polypropylene
vs. polylactic and
polypropylene
Lichtenstein in
local anesthesia
Mean:
12months
(1–16)
No recurrence,
postoperative pain lower
with SIS, full recovery
shorter with SIS
NR 1b
(9) Prospective
blinded
randomized trial
n= 201 Porcine dermal
collagen vs.
polypropylene
Open procedure 24months No difference in recurrence
rate, collagen repairs had
improved pain scores
NR 1b
Abstract only
(5) Double-blinded
RCT
n= 70
primary
inguinal
hernia
SIS vs.
polypropylene
Lichtenstein in
general or spinal
anesthesia
36months One recurrence in the PP
group; significant lower
pain degree for the SIS
group
NR 1b
(10) Prospective,
double-blinded,
single-center
randomized trial
n= 100 Biodesign
Inguinal Hernia
Matrix (IHM) vs.
polypropylene
Lichtenstein in
local anesthesia
12months Three recurrences in the
IHM group vs. 0 in the
polypropylene group
(p= 0.11). Persistent pain
trended higher in the
polypropylene group
Grant from
producer of
IHM
1b
(11) Prospective,
double-blinded,
multicenter
randomized trial
n= 172 Strattice vs.
Ultrapro
Lichtenstein in
local or general
anesthesia
3months No recurrence, no wound
complication, impairment
caused by the hernia
decreased significantly in
both groups, less
postoperative pain days 1
and 3 in the Strattice group
Grant form
producer of
Strattice
1b
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TABLE 2 | Characteristics and outcomes of studies reporting on inguinal hernia repair with the use of biologic mesh.
Reference Study design Patients characteristic Mesh material Intervention details Follow-up Outcome Conflict of
interest
LoE
(14) Retrospective
case series
n= 137 male patients
n= 16 emergency cases
Porcine dermis
(Zenoderm)
Modified
Notaras-technique
Mean:
48months
Two recurrences
(1.25%)
NR 4
(18) Retrospective
case series
n= 15 potentially or
grossly contaminated
field
SIS Laparoscopic TAPP Median:
19months
(1–30)
No recurrence NR 4
(17) Retrospective
case series
n= 10 sports hernia.
Professional or amateur
athletes
SIS TEP; 7 cm10 cm
mesh size, fixation with
five tacks (Protack),
one patient had only
fibrin glue fixation
12months Nine improved,
one not
NR 4
(15) Retrospective
case series
n= 38 patients with 45
primary and 6 recurrent
inguinal hernias
SIS TEP; 7 cm10 cm
mesh size, fibrin glue
fixation
Mean:
13months
(1–30)
One recurrence
(2%), three
patients chronic
pain (7.9%)
NR 4
(16) Retrospective
case series
n= 11 SIS TAPP; Fibrin glue
fixation
Mean:
14.51month
One recurrence NR 4
In a prospective RCT (7), Lichtenstein inguinal hernioplasty
was performed in local anesthesia, using prolene (PP) or vypro
(polylactin and PP) or SIS. The median follow-up was 12months,
with a range of 1–16months. No recurrent hernias were observed.
Postoperative pain (visual analog scale) and discomfort were
lower in patients with SIS. There was a tendency toward a higher
incidence of pain and discomfort in the vypro and prolene group.
In an abstract as interim report, Macklin et al. (8) have treated
140 patients in a prospective RCT receiving either PP or collagen
mesh. Postoperatively, there was an increase in hematoma in the
PP group (p= 0.048). Infection and inflammation were similar
postoperatively and at 3months. There was one recurrent hernia
in each group in 1 year.
Initial results showed that collagen mesh is an effective method
of providing tissue repair in primary inguinal hernia.
In another abstract, Ridgway et al. (9) reported on a blinded
randomized controlled trial comparing porcine dermal colla-
gen with PP for primary inguinal hernia repair in 201 patients.
Recurrence, inflammation, infection, and hematoma rates were
comparable at all time intervals. Collagen repairs had improved
pain scores at 2 years. The authors concluded that inguinal hernia
repair using modified porcine dermal collagen can be performed
successfully.
In another prospective, randomized, double-blinded, single-
center study (10), the use of a Biodesign Inguinal Hernia Matrix
(IHM) vs. a PPmesh for Lichtenstein operation was compared for
100 patients. The follow-up period was 1 year. Three recurrences
were observed in the IHM group and none in the PP group
(p= 0.11). There was a higher tendency toward persistent pain in
the PP group (6 vs. 4%).
Likewise, in a prospective randomized, double-blinded multi-
center study (11) that compared the use of Strattice vs. Ultrapro
for Lichtenstein operation in 100 patients, no differences were
observed in the wound complication rate after 3months. No
recurrences occurred in any of the two groups, nor any difference
was seen in postoperative pain after 3months.
On pooling, the results of the three (5, 7, 10) aforementioned
RCTs, each of which used small intestinal submucosa (SIS), no
difference was found in the recurrence and pain rate after 1 year
(12). Only the discomfort rate was lower in the SIS group, but the
seroma rate was higher. Likewise, these findings are confirmed in
the meta-analysis of four (5, 7, 10, 11) RCTs (13).
In a retrospective case series Holl-Allen (14) published the
results of 137 consecutive unselected male patients with inguinal
hernias treated with Zenoderm as the repair material after a mean
follow-up of 48months. There have been two indirect recurrences
after 11 and 14months, representing a low recurrence rate of
1.25%.
In three retrospective case series (15–18) with 10–38 patients,
inguinal hernias were repaired in an endoscopic technique
(TEP, TAPP) with SIS. During a mean follow-up period of
12–14.5months, a recurrence rate of 2 and 9.1% was observed,
respectively (15, 16). No improvement in symptoms was seen in
one patient with a sports hernia following TEP operation with
SIS (17). In another study the biological meshes (SIS) were used
successfully even in a potentially contaminated setting, i.e., with
incarcerated/strangulated bowel within the hernia or coincident
with a laparoscopic cholecystectomy/colectomy as well as in a
grossly contaminated field (i.e., gross pus or fecal spillage) (18).
Discussion
Inguinal hernias can be repaired with biological meshes, and with
a reasonable recurrence rate. This applies for a period of 3 years for
the Lichtenstein operation and of 1 year for the endoscopic TEP
and TAPP techniques. As such, biological meshes can be used as
an alternative in a potentially contaminated field for incarcerated
inguinal hernia or coincident with a laparoscopic cholecystectomy
or colectomy as well as in a setting grossly contaminated with
pus or fecal spillage (18). However, this was a retrospective case
series rather than a RCT. The RCTs identified demonstrated the
equivalence of a biological mesh and the PP mesh in terms of the
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recurrence rate as well as reduced pain at rest, on coughing or on
movement. Because of the very small sample size, the equivalence
of biological meshes and synthetic meshes with regard to recur-
rence rate and reduced pain must be verified in further studies.
Besides, in none of the studies were the higher costs incurred for
the biological meshes analyzed. Since the biological meshes do not
have any major advantages over the synthetic meshes with respect
to themost important assessment criteria, at present they can only
be recommended for situations involving a contaminated surgical
field.
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Appendix
BioMesh Study Group
Ferdinand Köckerling (Chairman), Stavros Antoniou, René
Fortelny, Frank A. Granderath, Markus Heiss, Franz Mayer, Marc
Miserez, Agneta Montgomery, Salvador Morales-Conde, Filip
Muysoms, Alexander Petter-Puchner, Rudolph Pointner, Neil
Smart, Marciej Smietanski, and Bernd Stechemesser.
Aim
The BioMesh Study Group has set itself the task of iden-
tifying how best to use biological meshes for the various
indications. The first step toward achieving that goal is to
compile systematic reviews of the different indications on the
basis of the existing literature. The available literature sources
will be evaluated in accordance with the Oxford Centre for
Evidence-basedMedicine-Levels of Evidence (March 2009). Next,
based on the review findings corresponding Statements and
Recommendations are to be formulated in a Consensus Con-
ference for the use of biological meshes for the different indi-
cations. The findings of the Consensus Conference are then to
be summarized for a joint publication. This present publica-
tion is part of the project undertaken by the BioMesh Study
Group.
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